Table 3.
Clinicopathological characteristics of all patients with an ERα-positive lymph node metastasis.
| No | Gender | Age | ERα IRS | Localization | Grading | R-Status | pTNM | Smoking | Alcohol | Adjuvant Therapy | Survival (Months) | Time to Recurrence (Months) |
Comment | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lymph Node Metastasis | Primary Tumor | |||||||||||||
| 1 | female | 53 | 5.00 | 1.00 | Floor of mouth | G2 | R0; cm (4 mm) |
pT1 pN2b cM0 | + | + | + | 69 (alive) |
none | |
| 2 | male | 51 | 3.00 | 0 | Floor of mouth | G2 | R0; cm** |
pT1 pN2c cM0 | + | + | + | 30 | none | |
| 3 | male | 51 | 3.75 | * | Lower jaw | G3 | R0 ** | pT2 pN2b cM0 | + | + | + | 13 | none | Adj. therapy was delayed due to a strongly reduced general condition. It was carried out 2.5 months after surgical approach. |
| 4 | female | 62 | 10.00 | 1.33 | Floor of mouth, lower jaw, tongue | G2 | R1 | pT4a pN2c cM0 | + | + | + | 16 | 10 | |
| 5 | female | 80 | 5.00 | 0 | Floor of mouth | G3 | R0; cm (4 mm) |
pT1 pN2b cM0 | − | − | − | 76 | Patient lost to clinical follow-up | Patient refused recommendation for adj. therapy. The patient did not show up for regular clinical follow-up. However, the patient died 76 months after first diagnosis. |
* Not available; ** no information on exact safety margin; cm: close margin.